A New Target of Peritoneal Ultrafiltration Failure in Peritoneal Dialysis Patients：Peritoneal Angiogenesi

J4 ›› 2011, Vol. 10 ›› Issue (6): 64-67.

A New Target of Peritoneal Ultrafiltration Failure in Peritoneal Dialysis Patients：Peritoneal Angiogenesi

Objective：To analyze the major causes and tactics of uhrafihration failure in long peritoneal dialysis patients．Methods：Through a large number of documents，we reviewed the characteristics of peritoneal angiogenesis research progress from the current points of incidence of peritoneal uhrafihration failure，and the change of peritoneal structure and funelion．Results：Vm‘ious eauses can stimulate the expression of VEGF in peritoneal membrane tissue，and promote the proliferation of new vascular，which result in increased effective peritoneal surface area of peritoneal membrane and reducd uhrafihration．Peritoneal angiogenesis was the main reason of peritoneal ultrafiltration failure．Conclusion：Peritoneal angiogenesis was the major reason of peritoneal ultrafihration failure，which WflS also the reseamh focus．There were a variety of methods to interfere the formation of new blood vessels．

The Second Afiliated Hospital of Kunming Medcine College，Kunming 650021，China

Online:2011-06-01 Published:2011-06-01

Abstract

Abstract:

Key words: peritoneal dialysis, ultrafiltration failure, VEGF

CLC Number:

R459．5

References

[1]Mujais S，Nolph K，Gokal R，et a1．Evaluation and management of uhrafihration problems in peritoneal dialysis．International Soeiety for Pertioneal Dialysis Ad Hoe Cornmittee on Uhrafitration Management in Peritoneal Dialysis[J]．Perit Dial Int，2000，20(4)：15～21．
[2]郑智华，马祖等，郝元涛，等．持续性非卧床腹膜透析患者生存质量影响因素的研究[J]．中华肾脏病杂志，
2005．21(5)：290—294．
[3]Yuan J Z，Fang W，Ni z H，et al．Peritnoeal Moq)hologie changes in a pelitoneal dialysis rat model correlate with angiopoietin／Tie-2[J]．Pediatr Nephrol，2009，24(3)：163-170．
[4]Smit W，Sehouten N，vail den Berg N，et al．Analysis of he prevalen( and eatlses of uhrafihration faihue during long—term peritmleal dialysis：a eorss—sectional study[J]．Perit Dial lnt，2004，24(6)：506—508．
[5]林爱武，钱家麒．如何解决腹膜透析患者的容量超荷问题[J]．肾脏病与透析肾移植杂志，2006，15(1)：82—84．
[6]Williams J D，Craig K J，Topley N，et a1．Peritoneal Biopsy Study Group：Mocphologie ehanges in the perit(meal membrane of patients with renal disease[J ]．J Am Soe Nephrol，2002．13(2)：470—479．
[7]Rippe B，Venturoli D．Simulations of ()Sill()tie uhrafiltration failure in CAPD using a serial three —— pore membrane／fiber mattix model [J]．Am J Physiol Renal Physiol，2007,292(2)：1035—1043．
[8] Llu T，Owen W，Yu YM，et aI．Arginine，eitndline，and nilrie oxide melabolisin in end—stage renal disease patients．J Clln Invest．2000．105(9)：l2j7一l225．
[9]Duyndnm MC，Hilhorst MC，Schluper HM，et a1．Vascular endothelial growth factor——165 over expression stimulales angiogenesis and induces cyst fornmtion and maerophage itfihration in human ovarian cancer xenografls[J]．Am J Pathnl，2002,160(5)：537—554．
[10]杨琼琼，叶任高，阳晓，等．含糖透析液对慢性腹膜透析大鼠腹膜功能及间皮细胞形态的影响[J]．中国病理生
理杂志，2004，20(8)：l377—1380．
[1 1]王欣，余学清，贾占军，等．转化因子Bl及其信号蛋白在大鼠急性腹膜炎模型腹膜组织中的表达及作用[J]．
中华肾脏病杂志，2004，20(6)：391—395．
1l2jZareie M，De Vriese A S，Hekking I H，et a1．Imumnopatho logicalchanges in a uraenlie rat model for peritoneal dialysis[J]．Neph,’ol Dial rransplant，2005，20(8)：1350—1361．

[13 ] Zweers M M，Struiik D C，Stnil ，el al，Vascular rndothelia growth factor in peritoneal dialysisIa hmgitudinal foilowup[J]．Lab Clin Me(1，2001，l37(2)：l25～l32．
[14] A roar M K，Reddy K，Balakum ar P．Ttie low dose eont bination of fenlfibtate alld rodiglitaznne hahs the progression of diabetes—induced eeperimental nephropathy[J ]．Eur J Pharm aeo，2010，636(7)：137-l44．
[15]严豪，方炜，李振元，等．可溶性酪氨酸激酶2融合蛋白对尿毒症腹膜透析大鼠腹膜形态和功能的影响[J J．中华
肾脏病杂志，2010，26(7)：525—529．